Test Overview
Clinical Utility
Elevated levels of serum NSE are reported in patients with small cell carcinomas primarily of lung origin. Patients with neuroblastomas may
also have high levels of NSE. Serum NSE can be used to monitor recurrence or progression of tumor in these cancer patients. Daily serial
monitoring of serum NSE may also be used in comatose patients to assess neuronal damage. High NSE levels in comatose patients at 24
and 48 hours post cardio-pulmonary resuscitation have been associated with poor outcome. Hemolysis can cause false positive results.
Method
Enzyme Immunoassay (EIA)
Result Included
Neuron Specific Enolase (NSE)
Specimen
Specimen Type
SerumVolume
Sample Volume
1 mL
Minimum Volume
0.3 mL
Collection & Handling
Handling Information
Store and send refrigerated.
Stability
| Ambient | Refrigerated | Frozen |
|---|---|---|
| 7 days | 7 days | 30 days |
Performance & Interpretation
Turnaround Time
6 days
Results
Name
Units
Reference Range
Conversion
-
Neuron Specific Enolaseng/mL≤ 14
Referral Location
Out-of-Country
Test Version
Last Updated
2022-08-25